|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Oncternal Therapeutics (NASDAQ: ONCT) through any online brokerage.
The latest price target for Oncternal Therapeutics (NASDAQ: ONCT) was reported by Oppenheimer on 2021-04-07. The analyst firm set a price target for 14.00 expecting ONCT to rise to within 12 months (a possible 151.80% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $5.56 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Oncternal Therapeutics.
There is no upcoming split for Oncternal Therapeutics.